Originally published In Press as doi:10.1074/jbc.M910297199 on March 21, 2000
J. Biol. Chem., Vol. 275, Issue 25, 18985-18994, June 23, 2000
Individual Subunits of the Eukaryotic Cytosolic Chaperonin
Mediate Interactions with Binding Sites Located on Subdomains of
-Actin*
Gillian M.
Hynes and
Keith R.
Willison
From the Institute of Cancer Research, Chester Beatty Laboratories,
London SW3 6JB, United Kingdom
Received for publication, December 22, 1999, and in revised form, March 13, 2000
 |
ABSTRACT |
The chaperonin containing TCP-1 (CCT) of
eukaryotic cytosol is composed of eight different subunit species that
are proposed to have independent functions in folding its in
vivo substrates, the actins and tubulins. CCT has been loaded
with 35S-
-actin by in vitro translation in
reticulocyte lysate and then subjected to immunoprecipitation with all
eight anti-CCT subunit antibodies in mixed micelle buffers, conditions
that disrupt CCT into its constituent monomers. Interactions between
35S-
-actin and isolated CCT
, CCT
, CCT
, or
CCT
subunits are observed, suggesting that polar and electrostatic
interactions may mediate actin binding to these four CCT subunits.
Additionally, a
-actin peptide array was screened for CCT-binding
sequences. Three regions rich in charged and polar amino acid residues,
which map to the surface of native
-actin, are implicated in
interactions between actin and CCT. Several of these biochemical
results are consistent with the recent cryo-electron microscopy
three-dimensional structure of apo-CCT-
-actin, in which
-actin is
bound by the apical domains of specific CCT subunits. A model is
proposed in which actin interacts with several CCT subunits during its
CCT-mediated folding cycle.
 |
INTRODUCTION |
The chaperonins are a class of molecular chaperones that mediate
the folding of non-native polypeptides using an
ATP-dependent reaction cycle (1). Chaperonins are composed
of two back-to-back rings containing either seven, eight, or nine
60-kDa subunits per ring, and they comprise two evolutionary divergent
groups: the type I and type II chaperonins (2). Generally, chaperonins are composed of one, two, or three subunit species (3), but, exceptionally, the eukaryotic type II chaperonin containing TCP-1 (CCT)1 has eight different
subunits per 8-fold pseudosymmetric ring (4), and each is proposed to
be arranged in a fixed topology (5-7).
It is suggested that each CCT subunit has evolved a specific
independent function while maintaining the common property of ATPase
activity (8, 9). The specific functions of individual CCT subunits may
be associated with the provision of different polypeptide substrate
binding sites, and thus individual subunits of CCT may play different
roles in substrate interaction (5, 10). The observation that the
sequences of the eight constitutively expressed CCT subunit types
(CCT
-CCT
) are most divergent from each other in their apical
domains (11) and that the apical domains of these eight orthologues are
highly conserved between higher and lower eukaryotes supports the idea
of the apical domain region of each subunit providing an individual and
evolutionarily conserved role within the CCT complex related to
substrate binding. This scenario is plausible because the major
in vivo substrates of CCT, the actins and tubulins, are
among the proteins most conserved in comparison across all eukaryotic
species (10).
Llorca et al. (12) recently determined a structure of
-actin complexed with CCT by cryo-electron microscopy and
three-dimensional reconstruction of single particles. Despite the fact
that the images are at low resolution, around 30 Å, it appears that a
stable intermediate can exist in which
-actin is bound to two CCT
subunits in either of two 1:4 arrangements (CCT
-CCT
and
CCT
-CCT
) in the 8-fold ring, via the tips of the large and small
domains. The complexes were prepared in the absence of ATP and,
therefore, CCT is unliganded by adenine nucleotides (apo-CCT). It is
suggested that actin bound by apo-CCT may be native-like, albeit opened up across its nucleotide binding cleft, and thus presumably in a
nucleotide-free state (12). This recent structural analysis of the
apo-CCT-
-actin complex (12) raises the strong possibility that CCT,
at least in one stage of its reaction cycle with this particular
substrate, may not be recognizing residues predominantly located in the
hydrophobic core of an unstructured folding intermediate but rather
those on the surface of a native-like folding intermediate.
Here we have undertaken a biochemical approach to test the model that
individual subunits of CCT are involved in interactions with newly
synthesized actin and that specific sequences in actin are bound by
CCT. Immunoprecipitation of CCT-
-actin complexes under conditions of
various stringency in buffers containing single and combinations of
detergents revealed that several interactions between specific CCT
subunits and actin are highly resistant to disruption in mixed micelle
buffers, conditions that cause complete disruption of the CCT
hexadecamer into its constituent subunits. In addition, a set of
overlapping 15-mer peptides covering the entire 375 residues of mouse
-actin was screened for apo-CCT binding activity. We find that the
peptides that bind CCT strongly are derived predominantly from loop and
-strand regions located on the surface of native actin. As expected
for surface exposed regions of proteins, the CCT-binding peptides
contain charged and polar residues in addition to nonpolar ones. These
results suggest that some steps in the CCT-actin interaction pathway
may be mediated through nonhydrophobic interactions. Furthermore, these
data allow us to begin discriminating various levels of a complicated
series of interactions that take place between actin and CCT during
folding. We propose that some critical interactions are mediated
between specific CCT subunits and actin folding intermediates and that
hydrophilic loops and strands, which in native actin are found located
on the surface, are components of the binding sites recognized by
CCT.
 |
EXPERIMENTAL PROCEDURES |
cDNA Plasmids and in Vitro Protein
Expression--
Full-length
-actin cDNA (residues M1-F375 of
human
-actin) was cloned into pCITE vector (Novagen).
Ha-Ras-
-actin subdomain 4 fusion cDNA, abbreviated as
-actin.sub4 (residues 1-168 of human Ha-Ras linked by Ser-Arg to
residues Leu178-Phe262 of human
-actin in
pBluescript SK
vector; Stratagene), was described
previously by Llorca et al. (12). All eight constitutively
expressed mouse CCT subunit cDNAs in pBluescript SK
were used as described by Liou et al. (13). In
vitro transcription/translation reactions were carried out in the
TNTTM rabbit reticulocyte lysate (Promega) in the presence
of 40 µCi (40 pmol) of [35S]L-methionine
(Amersham Pharmacia Biotech)/50 µl of volume as described (13).
Individual translation reactions were performed at 30 °C for 22 min
(
-actin), 60 min (CCT
, CCT
, CCT
, CCT
, CCT
, CCT
,
CCT
, or CCT
-1 subunits), or 45 min (
-actin.sub4).
Immunoprecipitation of
-Actin and
-Actin.sub4 Following in
Vitro Translation--
35S-Labeled full-length
-actin
and
-actin.sub4 produced by in vitro translation in
rabbit reticulocyte lysate were recovered by immunoprecipitation with
anti-CCT subunit antibodies (14, 15). Following in vitro
translation and sucrose gradient fractionation of rabbit reticulocyte
lysate, three different types of immunoprecipitation experiment were performed.
In the first set of reactions (see Fig. 1), 114-µl aliquots of the
fractions containing the hexadecameric CCT peak (20-23% sucrose) (16)
were made up to a volume of 500 µl with either Nonidet P-40
immunoprecipitation buffer (50 mM HEPES, pH 7.2, 90 mM KC1, 0.5% Nonidet P-40 (final detergent concentration)) or mixed micelle immunoprecipitation buffer (50 mM HEPES,
pH 7.2, 100 mM NaC1, 1% sodium deoxycholate, 1% Nonidet
P-40, 0.1% SDS (final detergent concentrations)) and incubated with 5 µl of antibody for 2 h on ice. Protein A-Sepharose beads (Sigma)
in either Nonidet P-40 buffer or mixed micelle buffer (packed volume,
50 µl) were added, and reactions were mixed for 2 h at 4 °C.
The beads were then washed three times with 500 µl of Nonidet P-40
buffer or mixed micelle buffer.
In the second set of reactions (see Fig. 2C), fractions
containing unlabeled hexadecameric CCT peak (20-23% sucrose) were mixed with the fraction containing 35S-labeled
-actin
monomers (13% sucrose). The samples (total volume, 94 µl) were made
up to a volume of 500 µl with either Nonidet P-40 or mixed micelle
immunoprecipitation buffer and incubated with 5 µl of antibody for
2 h on ice. Protein A-Sepharose beads (Sigma) in either Nonidet
P-40 buffer or mixed micelle buffer (packed volume, 50 µl) were
added, and reactions were mixed for 2 h at 4 °C. The beads were
then washed three times with 500 µl of Nonidet P-40 buffer or mixed
micelle buffer.
In the third set of reactions (see Fig. 3), 130-µl aliquots of the
sucrose fractions containing free CCT subunits and
-actin monomers
(13-17% sucrose) were made up to a volume of 1 ml with Nonidet P-40
immunoprecipitation buffer and incubated with 10 µl of antibody for
2 h on ice. Protein A-Sepharose beads in Nonidet P-40 buffer
(packed volume, 100 µl) were added, and reactions were mixed for
2 h at 4 °C. The beads were then divided into two equal
samples, and one sample was washed three times with 500 µl of Nonidet
P-40 buffer, whereas the other sample was washed three times with 500 µl of mixed micelle buffer.
Beads were resuspended in Laemmli loading buffer for analysis by
SDS-PAGE on 8% (full-length
-actin) or 12.5% (
-actin.sub4) gels. 35S-Labeled protein bands were visualized by
autoradiography and quantitated by PhosphorImager analysis on a Storm
860 (Molecular Dynamics).
Purification of Hsc/Hsp70 Proteins--
Twenty mouse testes were
homogenized in 10 ml of ice-cold lysis buffer (0.1% bovine serum
albumin, 0.5 mM DL-lactic acid, 1 mM pyruvic acid in PBS.A, pH 7.2) containing
CompleteTM protease inhibitors (Roche Molecular
Biochemicals) using a Polytron PT3000 (Kinematica). Debris was pelleted
by centrifugation in a Beckman SW28 rotor (25000 rpm, 1 h,
4 °C), and the supernatant lysate (12 ml) was layered onto a linear
sucrose gradient (10-40% w/w sucrose in 90 mM KCl, 50 mM TEA-HCl, pH 7.5). The gradient was centrifuged in a
Beckman SW28 rotor (25000 rpm, 16 h, 4 °C), and fractions (1 ml
each) were collected and analyzed by SDS-PAGE. The three fractions
enriched in both CCT and Hsc/Hsp70 were pooled, and sample volume was
brought up to 10 ml with column equilibration buffer (20 mM
TEA-HCl, pH 7.5, 5 mM
-mercaptoethanol, 5 mM
MgCl2, 50 mM NaCl). Hsc/Hsp70 proteins were
purified by ion exchange chromatography on a Hi-Trap column (Amersham
Pharmacia Biotech). The column was eluted with a linear gradient of 20 mM to 1 M NaCl in 4 bed volumes of column
equilibration buffer, and the fraction (1 ml) containing purified
Hsc/Hsp70 proteins was concentrated using a Millipore ultrafree
microconcentrator to a final volume of 200 µl.
Assay to Screen for Interaction between Molecular Chaperone
Proteins and an Immobilized
-Actin Peptide Array--
A set of 74 PepsetTM peptides (Meltek Scientific) was synthesized on
polyethylene solid phase pins in a 96-well format. Each peptide was
immobilized at the C terminus and contained 15 amino acid residues and
an acetyl N terminus. Peptides 1-73 scanned the primary structure of
mouse cytoplasmic
-actin (SwissProt:P02570), and starting from the
N-terminal peptide 1MDDDIAALVVDNGSG15 (peptide
1), each subsequent peptide was offset by 5 residues, i.e.
peptide 2, 6AALVVDNGSGMCKAG20; peptide 3, 11DNGSGMCKAGFAGDD25; etc. Peptide 74 contained
the epitope sequence for monoclonal antibody (mAb) 91A, which
recognizes CCT
(15, 17). A general assay was established to detect
the interaction of molecular chaperone proteins with the peptide array,
which involved mAb binding followed by enzyme-linked immunosorbent
assay detection. Nonspecific binding to the peptide pins was reduced by
incubation with precoat buffer (2% bovine serum albumin, 0.1% Tween
20 in PBS.A, pH 7.2) for 1 h at room temperature. Hsc/Hsp70
proteins were purified from mouse testis as described above, and CCT
was isolated from mouse testis as described previously (18). Purified
CCT (6.5 µg/ml) or Hsc/Hsp70 (675 ng/ml) in 100 ml of binding buffer
(50 mM HEPES, pH 7.2, 90 mM KCl, 0.5 mM MgCl2) were incubated with the peptide array
for 16 h at 4 °C. The pins were washed three times with PBS.A
for a total of 30 min and incubated with the appropriate mAb
(approximately 1.5 µg/ml in PBS.A) for 2 h at room temperature to detect CCT (mAb 91A) (15, 17) or Hsc/Hsc70 (mAb 3a3, Affinity Bioreagents). Following washing in PBS.A, the pins were incubated with
a secondary antibody conjugated to alkaline phosphatase (30 ng/ml in
PBS.A, Pierce) for 2 h at room temperature. The pins were washed
in PBS.A and incubated with p-nitrophenyl phosphate (Sigma)
in 96-well microtitre plate for 30 min in the dark. Absorbance at 410 nm caused by the conjugates was detected using a microplate reader
(model MR 710, Dynatech).
ATP-dependent Dissociation of CCT from
-Actin
Peptides--
The immobilized peptide array was incubated with CCT as
described above and, prior to the development step in
p-nitrophenyl phosphate, the peptide pins were incubated at
37 °C for 2 h in substrate release buffer (50 mM
HEPES, pH 7.2, 90 mM KC1, 2 mM MgCl2, 1 mM dithiothreitol, 1 mM ATP).
Interaction of Soluble Biotinylated Peptides with
CCT--
Biotinylated PepsetTM peptides (Meltek
Scientific) corresponding to residues 36-50 of mouse
-actin were
synthesized on polyethylene solid phase pins. After cleavage, each
peptide contained an amide C terminus and 19 amino acid residues
including a -SGSG linker to a biotin group at the N terminus. The set
consisted of the wild-type
-actin sequence
(biotin-SGSG-36GRPRHQGVMVGMGQK50), five mutant
peptides containing alanine scanning substitutions of residues GRPRH
(biotin-SGSG-ARPRHQGVMVGMGQK, biotin-SGSG-GAPRHQGVMVGMGQK, biotin-SGSG-GRARHQGVMVGMGQK, biotin-SGSG-GRPAHQGVMVGMGQK, and biotin-SGSG-GRPRAQGVMVGMGQK), and one mutant peptide where all five residues of the GRPRH core sequence were replaced by AAAAA (biotin-SGSG-AAAAAQGVMVGMGQK). The peptides were solubilized in 10%
acetic acid and analyzed by matrix-assisted laser desorption ionisation
time of flight mass spectrometry on a Finnegan Lasermat 2000, and
peptide concentration was determined by amino acid analysis. CCT (70 nM) was incubated with peptide (13.3 µM or
1.33 µM) in binding buffer (50 mM HEPES, pH
7.2, 90 mM KCl, 0.5 mM MgCl2) for
1 h on ice. CCT complex was resolved on 6% native PAGE gels, electrotransferred to nitrocellulose membrane, and incubated with Neutravidin-horseradish peroxidase (Pierce) (2 µg/ml in 2% bovine serum albumin in PBS.A) to detect the interaction between CCT and
biotinylated peptide.
Structural Analysis--
The image of the three-dimensional
structure of actin (1ATN) was rendered using PREPI (48).
 |
RESULTS |
Differential Interaction between CCT Subunits and Subdomains of
-Actin--
CCT in complex with 35S-labeled
-actin
was prepared under approximate physiological conditions by in
vitro translation in rabbit reticulocyte lysate followed by
sucrose gradient fractionation to separate actin in complex with
hexadecameric CCT away from actin monomers and free CCT subunits (13).
Initially, to follow CCT subunit recovery during immunoprecipitation,
each of the eight CCT subunits was 35S-labeled individually
and incorporated into rabbit CCT in reticulocyte lysate using the
single-ring mediated assembly cycle discovered by Liou et
al. (13). Two CCT preparations each having 35S-labeled
-actin and four 35S-labeled CCT subunit types were
prepared by sucrose gradient fractionation of five pooled in
vitro translation reactions (set 1 contained
35S-labeled
-actin and CCT
,
,
, and
-1,
whereas set 2 contained 35S-labeled
-actin and CCT
,
,
, and
). These two sets were mixed after fractionation but
prior to immunoprecipitation to produce CCT mixtures labeled in each of
the eight subunits (Fig. 1A,
lane S). Thus, in the following experiments it should be
borne in mind that no CCT complex contains more than one
35S-labeled component, be it specific CCT subunit or the
actin substrate. Immunoprecipitation of the pooled
35S-labeled CCT-
-actin mixtures with monoclonal
anti-CCT
antibody 23C (16, 17) in 0.5% Nonidet P-40 recovered all
eight CCT subunits and actin (Fig. 1A, lane N).
This is to be expected, because this nonionic detergent does not
disrupt CCT-substrate complexes (8, 16). Immunoprecipitation of
35S-labeled CCT-
-actin mixtures with monoclonal
anti-CCT
antibody 23C in mixed micelle buffer recovered only the
CCT
subunit but none of the other seven CCT subunit types (Fig.
1A, lane
), consistent with the fact that
incubation in mixed micelle buffers causes disruption of CCT complex
into its constituent subunits (16). However, some actin remains bound
to the CCT
subunit dissociated from holo-CCT by detergent (Fig.
1A, lane
). Immunoprecipitation of the
35S-labeled CCT-
-actin mixtures with the other seven
anti-CCT C-terminal epitope antibodies (14) in mixed micelle buffer
found that each antibody recovered its cognate CCT subunit and various
amounts of 35S-
-actin (Fig. 1A, lanes
,
,
,
,
,
, and
-1).

View larger version (37K):
[in this window]
[in a new window]
|
Fig. 1.
Immunoprecipitation of
CCT- -actin and
CCT- -actin.sub4 complexes. Autoradiogram
in A shows recovery of individual CCT subunits
(asterisk) and associated -actin (arrow) from
the 20 S sucrose peak by immunoprecipitation with the set of anti-CCT
subunit antibodies in Nonidet P-40 (lane N) and mixed
micelle buffers (lanes - -1) (14) (15). Lane
S indicates starting sample for immunoprecipitation
(i.e. 20S sucrose fraction), and lane N indicates
recovery of intact 35S-labeled CCT- -actin complexes in
0.5% Nonidet P-40. Lane B indicates background signal
obtained by incubation of starting sample with beads alone in mixed
micelle buffer. Samples displayed on 8% SDS-PAGE. Molecular mass
markers (kDa) are indicated on the right-hand margin of the
autoradiogram. B shows the relative recovery of each
35S-labeled CCT subunit upon immunoprecipitation in mixed
micelle buffer compared with CCT (value = 1) after
quantitation. Autoradiogram in C shows recovery of
35S- -actin (arrow) by anti-CCT subunit
antibodies. Lanes are annotated as in A. D shows quantitation of recovery of
35-S- -actin by each anti-CCT antibody in mixed micelle
buffer (signals to -1). Max indicates maximum signal recovered
in 0.5% Nonidet P-40 (lane N). Recovery (E) and
quantitation (F) of 35-S- -actin.sub4
(arrow in E) by anti-CCT subunit antibodies.
Lanes are annotated as in C, except 12.5%
SDS-PAGE was used. The lower species is an internally initiated
polypeptide beginning at methionine 67 of Ha-Ras (E. A. McCormack,
unpublished results).
|
|
Recovery of each CCT subunit by immunoprecipitation with its cognate
antibody under mixed micelle conditions was quantitated and is shown
graphically in Fig. 1B. There is a 10-fold range in recovery
that is probably a consequence of several variables, including antibody
affinity and accessibility of the C-terminal epitopes of individual CCT
subunits. These immunoprecipitations were repeated with unlabeled
CCT-35S-
-actin complexes (Fig. 1C), and the
data were quantitated to show the relative amount of actin recovered by
each anti-CCT subunit antibody (Fig. 1D). This experiment
was repeated several times with similar results, and the conclusion is
that 35S-
-actin is recoverable in complex with CCT
,
,
, and
under conditions that cause disruption of holo-CCT
into its constituent monomers. Certain CCT subunits are well recovered
by immunoprecipitation under mixed micelle conditions, such as CCT
(Fig. 1B), but do not appear complexed with actin under
these stringent conditions. It is, of course, possible that different
and weaker interactions are occurring between some CCT subunits and
actin, but these cannot be discerned under milder conditions, because
such conditions do not disrupt holo-CCT.
Overall, when these data are compared with the CCT-
-actin complex
model (12), some aspects are consistent, such as the substantial
-actin signals recovered with anti-CCT
and anti-CCT
antibodies, whereas others are not accountable, such as the substantial
-actin signals recovered with CCT
and CCT
antibodies.
Furthermore, an important interaction seen between CCT
and actin
subdomain 2 in the three-dimensional structure is only weakly
discernible under these immunoprecipitation conditions (Fig. 1,
C and D). Llorca et al. (12) also
determined a structure of apo-CCT bound to recombinant
-actin
subdomain 4 fused to Ha-Ras, named
-actin.sub4, in which the hybrid
protein appears to contact either CCT
or CCT
but not CCT
.
-Actin.sub4 interacts with CCT upon in vitro translation
in rabbit reticulocyte lysate, and the interaction is mediated through
actin subdomain 4 of the chimeric protein, because Ha-Ras does not
interact with CCT. Therefore, a similar immunoprecipitation analysis to
the experiment with
-actin was carried out on unlabeled CCT
complexed to 35S-
-actin.sub4 (Fig. 1, E and
F). The data are again consistent with the three-dimensional
reconstruction; these are the substantial 35S-
-actin.sub4 signals recovered with anti-CCT
and
anti-CCT
antibodies and the absence of any
35S-
-actin.sub4 signal with CCT
antibody. Again,
CCT
and CCT
produce positive interactions with
35S-
-actin.sub4, indicating a contribution of these CCT
subunits to associations with the large domain of actin.
A number of control experiments were performed to confirm that the
interactions between newly synthesized
-actin and CCT subunits are
productive (Fig. 2).
-Actin is
actively folded and processed to a non-CCT interacting monomer
conformation upon in vitro translation in rabbit
reticulocyte lysate (12), indicating that interaction between newly
synthesized
-actin and CCT is transient. The 20 S sucrose peak
containing CCT-35S-
-actin complexes was incubated with
Mg-ATP to induce release of bound substrate. Quantitation of
35S-
-actin recovery upon immunoprecipitation of CCT
indicates that a significant amount of 35S-
-actin is
released from CCT subunits in response to Mg-ATP and that the released
-actin is not rebound by CCT nor does it adhere nonspecifically to
the protein A-Sepharose beads (Fig. 2A).

View larger version (19K):
[in this window]
[in a new window]
|
Fig. 2.
Controls for specificity of
CCT- -actin interactions. A, the 20 S sucrose peak containing CCT-35S- -actin complexes was
incubated with 4 mM ATP, 2 mM MgCl2
for 1 h at 0 °C prior to immunoprecipitation with anti-CCT
antibody in 0.5% Nonidet P-40 buffer. Quantitation of
35S- -actin recovery by immunoprecipitation before
( ATP) and after (+ATP) incubation with Mg-ATP is shown. Background
signal obtained by incubation of starting sample (+ATP) with beads
alone in 0.5% Nonidet P-40 buffer is indicated by B. B, the fraction containing 35S-labeled -actin
monomers (13% sucrose) was incubated in the presence and absence of
DNase I for 30 min at 0 °C. Samples were resolved on a 6% native
PAGE gel. Autoradiogram indicates the shift and supershift of native
35S- -actin monomers in the presence of DNase I and DNase
I plus antibody, respectively. C, unlabeled CCT complex from
the 20 S sucrose peak was mixed with native 35S- -actin
monomers from the top fraction of a sucrose gradient (13% sucrose) and
used as the starting sample for immunoprecipitation. Autoradiogram
shows recovery of 35S- -actin (arrow) by
anti-CCT subunit antibodies (lanes , ,
, , and ) in 0.5% Nonidet
P-40 (lanes N) and mixed micelle (lanes M)
buffers. The two lanes marked B indicate
background signals obtained by incubation of starting sample with beads
alone in 0.5% Nonidet P-40 or mixed micelle buffers. Recovery of
35S- -actin from the same starting sample used in Fig.
1C by immunoprecipitation with the anti-CCT antibody in
0.5% Nonidet P-40 is shown in lane C. Lane S
represents 10% of the 35S- -actin counts present in each
starting sample (excepting lane C; represents 100% of
35S- -actin counts present in starting sample). Samples
were resolved on 8% SDS-PAGE gels. Molecular mass markers are
indicated on the right-hand margin of the
autoradiogram.
|
|
-Actin monomers, produced through the action of CCT during the
course of the in vitro translation reaction, sediment in the top fractions of the sucrose gradient (13-17% sucrose). A DNase I
shift assay indicates that these
-actin monomers have been folded to
a native conformation (Fig. 2B), presumably as a result of
their interaction with CCT, and that they retain their native conformation during fractionation. These native
35S-
-actin monomers were mixed with unlabeled CCT
complex, and immunoprecipitation reactions similar to those described
in Fig. 1 were performed (Fig. 2C). No interaction between
35S-
-actin and CCT subunits was detected in either 0.5%
Nonidet P-40 or mixed micelle buffers. This indicates that native
-actin is not bound by CCT complex, despite the input
35S-
-actin monomer counts being in 10-fold excess
compared with the 35S-
-actin counts preloaded on CCT by
in vitro translation under physiological conditions (Fig.
1). This demonstrates that the specific interactions detected between
newly synthesized
-actin and CCT subunits upon in vitro
translation do not occur upon mixing CCT and folded
-actin monomers.
Furthermore, nonspecific interactions between CCT subunits and
-actin do not occur either in Nonidet P-40 or in mixed micelle
buffers during the course of the immunoprecipitation experiments.
Dissociated CCT
and CCT
Interact with Native
-Actin
Monomers in Nonionic Detergent--
In rabbit reticulocyte lysate and
the cytosol of other eukaryotic cells, it has been demonstrated that
CCT subunits can exist as populations of free monomers and
microcomplexes as well as components of the 900-kDa hexadecameric CCT
complex (5, 13, 19-21); however, the function of these free CCT
subunits and microcomplexes within cells is not yet fully understood.
Free CCT subunits dissociated from the holo-chaperonin in lysate
co-sediment with the native
-actin monomers in sucrose gradients at
13-17% sucrose. Further immunoprecipitation experiments were conducted to investigate whether any free CCT subunits could interact with the monomeric folded actin. An interaction preserved in nonionic detergent was observed between dissociated CCT
and CCT
and native
-actin monomers. Fig. 3 shows that
35S-
-actin is recovered upon immunoprecipitation with
anti-CCT
and anti-CCT
antibodies in 0.5% Nonidet P-40. This is
presumably a qualitatively different interaction to the one observed
when immunoprecipitating from the fractions containing
holo-CCT-
-actin, because these interactions between
-actin and
CCT
or CCT
are not preserved under mixed micelle conditions.
Conversely, the mixed micelle-resistant interactions between
-actin
and CCT
or CCT
derived from holo-chaperonin are not observed here
in mixtures of free CCT monomers and native
-actin monomers.
Although these results demonstrate that the interaction between folded actin monomers and dissociated CCT
and CCT
subunits can be
maintained under these experimental conditions, the physiological
relevance of these associations is unclear. They could reflect aspects
of the CCT disassembly cycle (13) in which
-actin departs from holo-CCT still bound by some subunit(s). Alternatively, there could be
a role for these two CCT subunits, when dissociated from holo-CCT in
the stabilization of actin monomers (21). Holo-CCT does not interact
with native
-actin monomers (Fig. 2C). The observation
that two CCT subunits, which are able to interact strongly with actin
in holo-CCT, CCT
, and CCT
, do not appear to participate in
associations with native conformers of actin supports the recent
structural model of apo-CCT-
-actin (12).

View larger version (24K):
[in this window]
[in a new window]
|
Fig. 3.
Immunoprecipitation of dissociated CCT
subunit- -actin monomer complexes. Two
mixtures of four 35S-labeled CCT subunits and
35S- -actin taken from the sucrose gradient fractions
containing dissociated CCT subunits and native -actin monomers
(13-17% sucrose) were used as the starting sample for
immunoprecipitation with the set of anti-CCT subunit antibodies.
Autoradiograms show recovery of individual CCT subunits
(asterisk) and associated -actin (arrow) in
0.5% Nonidet P-40 (lanes N) or mixed micelle (lanes
M) buffers. Left panel shows immunoprecipitations from
the mixture of 35S-labeled CCT , CCT , CCT ,
CCT -1, and -actin, and the right panel shows
immunoprecipitations from the mixture of 35S-labeled
CCT , CCT , CCT , CCT , and -actin. In each panel,
lane S indicates starting sample for immunoprecipitation,
and lane B indicates background signal obtained by
incubation of starting sample with beads alone in 0.5% Nonidet P-40
buffer. Immunoprecipitates were resolved on 8% SDS-PAGE gels.
Molecular mass markers are indicated on the right-hand side
of each autoradiogram.
|
|
Solid Phase
-Actin Peptide Array Screen for CCT Binding
Sequences in
-Actin--
We also took a completely separate
approach to investigate specific interactions between CCT and defined
regions of actin. A set of 73 immobilized peptides scanning the primary
structure of mouse
-actin (375 residues) was screened for
interaction with mouse testis CCT. Each peptide was 15 residues in
length, and subsequent peptides were offset by 5 residues. The assay to
detect the interaction of CCT with individual peptides involved
sequential incubation with mouse testis CCT, a monoclonal antibody,
91A, to the CCT
subunit (14, 15, 17), and a secondary antibody conjugated to alkaline phosphatase. Immune conjugates were then detected in an enzyme-linked immunosorbent assay. Fig.
4A shows that CCT interacts
with high affinity with 16 peptides distributed throughout the primary
structure of
-actin. Previous studies have demonstrated that CCT can
be induced to release bound substrates in the presence of ATP (22).
Interaction of the peptides with CCT followed by incubation in 1 mM ATP for 2 h at 37 °C reduced the bound CCT
signal on 11 of the peptides (Fig. 4B). One signal (number
74) represents interaction between the antibody probe and a peptide
containing the 91A mAb epitope sequence (mouse CCT
, 454VAKLRA459) (15) and is seen with antibody
incubation alone (Fig. 4C) but is not affected by incubation
with ATP (Fig. 4B). This signal thus represents the maximum
obtainable in this assay. During the course of these experiments, the
-actin peptide array was reprobed again 15 times, which involved
stripping of bound protein and regeneration of peptides. It concerned
us that the negatively binding peptides might reflect poor synthesis on
a particular pin or chemical damage to peptides after repeated probing
and regeneration. Therefore the peptide array was probed (probing number 16) with anti-actin monoclonal antibody AC-40 (Sigma), which
recognizes an epitope located at the C terminus of
-actin residues
365-375. Peptide number 73 reacted strongly with the mAb despite never
having previously supported a signal above background (giving a signal
of approximately 63% of the maximum possible; data not shown).

View larger version (19K):
[in this window]
[in a new window]
|
Fig. 4.
Identification of CCT binding sites on
-actin. A set of immobilized peptides scanning
the primary structure of mouse cytoplasmic -actin (1-73 in the
array) was screened with mouse testis CCT; the interaction of CCT was
detected with mAb 91A in an enzyme-linked immunosorbent assay
(A). Interaction with CCT followed by incubation in 1 mM ATP for 2 h at 37 °C reduced the bound CCT
signal on some, but not all, of the peptides (B). Peptide 74 contains the 91A mAb epitope sequence and is seen with antibody
incubation alone (C) and is not affected by incubation with
ATP (B). The -actin peptide array was also screened with
mouse testis Hsc/Hsp70 (D) using a similar monoclonal
antibody-based detection assay; the interaction of Hsc/Hsp70 was
detected with pan-Hsc/Hsp70 mAb, clone 3a3 (Affinity
Bioreagents).
|
|
We also investigated which sequences in the
-actin peptide array
were recognized by members of a different eukaryotic cytosolic molecular chaperone family. The peptides were screened for interaction with mouse testis Hsc/Hsp70 proteins, which are homologues of bacterial
DnaK. Fewer
-actin peptides are bound by Hsc/Hsp70 than CCT, despite
using a 9-fold molar excess of Hsc/Hsp70 compared with CCT to screen
the array (Fig. 4D). Some of the peptides are recognized by
both chaperones (Fig. 4, A and D). Different
Hsp70 family members are known to display different peptide binding specificities; however, the common feature recognized is defined as a
stretch of at least seven residues that includes large hydrophobic and
basic amino acids but few or no acidic residues (23). Several of the
actin peptides bound by Hsc/Hsp70 are enriched in large aliphatic
residues, particularly leucine, isoleucine, and valine, and the
strongest reacting peptide, number 35 (LPHAILRLDLAGRDL), contains
several leucines and basic residues compatible with the DnaK binding
motif as defined by Rudiger et al. (24, 25). Furthermore,
this peptide sequence is located as a buried
-strand in native
actin. We conclude from probing the
-actin peptide array with
Hsc/Hsp70 and CCT isolated from the same cell type that their
recognition patterns are different, despite overlapping to some degree,
which may reflect their functions in recognizing early and late stage
protein folding intermediates, respectively (26).
Definition of the
-Actin Sites--
A number of
three-dimensional crystal structures of native actin molecules have
been determined (27-29). Firstly we note, obviously, that these
three-dimensional native actin structures cannot inform us accurately
of the structure(s) of actin folding intermediate(s) recognized by CCT,
because native actin cannot be bound by CCT; nevertheless the native
structures give us views of secondary structural elements that may
already be formed in the folding intermediates.
The CCT-binding 15-mer peptide segments were mapped onto the native
actin monomer structures. Table I shows
that the peptides that interact with CCT are distributed throughout the
primary structure of
-actin. However, these CCT interacting sites
are grouped in only three main locations in
-actin in
three-dimensional space, as determined by examination of the x-ray
structures of
-actin-DNase I complex (27) and
-actin-profilin
complex (28). These interaction sites were therefore named
-actin
sites I, II, and III, with each site having two components, i and ii
(Table I). Only the 11 peptide signals that diminished in response to ATP incubation were classified as
-actin sites; nevertheless, other
positively reacting peptides (e.g. peptides 26, 28, 35, 39, and 70; Table I) may indeed contain bona fide CCT
interacting motifs.
A Van der Waals' surface diagram of monomeric actin, highlighting
residues contained within
-actin sites I-III (Fig.
5A), indicates that these
amino acids are predominantly exposed on the surface of the native
molecule in subdomains 2, 3, and 4. This was unexpected, because type I
chaperonins recognize hydrophobic residues that are buried in native
proteins (1), and two groups have proposed that hydrophobicity is
important for CCT-recognition of tubulin (30) and actin (31). The sites
are predominately located on the front surface of native G-actin
(standard view) (Fig. 5, A and B), further
indicating the specific nature of the interaction between CCT and
actin. We analyzed the distribution of surface charge and
hydrophobicity on actin and found no significant differences between
the front versus the back of the molecule.

View larger version (91K):
[in this window]
[in a new window]
|
Fig. 5.
Model of CCT interaction with
-actin: interaction between sites on both sides of
the nucleotide binding cleft of actin. A, Van der Waals'
surface diagram of native G-actin highlighting all the residues of the
11 peptide sequences used to define -actin sites I, II, and III (see
Table I). The front (left) and back (right) views
of native actin structure are shown, indicating that the peptide
sequences comprising -actin site I (red), II
(green), and III (blue) are exposed to the
surface. Subdomains 1-4 of actin are numbered at the
corners. B, ribbon diagram of native G-actin
showing the same front (left) and back (right)
views. -Actin sites I, II, and III and subdomains of actin are
indicated as in A.
|
|
The ribbon diagrams depicting secondary structural elements of actin
(27) (Fig. 5B) indicate that
-actin sites I-III are located predominantly in loop and
-strand regions. The peptide sequences corresponding to
-actin sites I-III share no consensus sequence or any obvious similarities in amino acid sequence or side
chain characteristics. This observation may suggest that CCT subunits
recognize specific sequence motifs in actin (Table I). If
surface-located loops and
-strands are indeed the main elements of
actin folding intermediates recognized by CCT, it is understandable why
the peptide screening assay yielded positive signals with 15-mer peptides.
An analysis of the domain motions in actin, using four available
crystal structures, indicates that a number of conformationally variable loops are included within the
-actin sites (32). According to the two published models of F-actin structure (33, 34), residues
within all three
-actin sites would be involved in intersubunit contacts in the actin filament. Furthermore, residues contained within
-actin sites I and II contribute to the binding site for DNase I
(Fig. 6A) (27), an
actin-monomer binding protein that inhibits filament assembly.

View larger version (29K):
[in this window]
[in a new window]
|
Fig. 6.
Analysis of -actin
site I. A, sequences around -actin site I in
subdomain 2 are contacted by DNase I. Amino acid sequence and secondary
structure elements of -actin site I. Arrows, -strands;
cylinder, -helix. Asterisks indicate residues
contacted by DNase I, and the open arrow represents a
-strand conformation induced by DNase I binding. B,
interaction of CCT with soluble peptides containing alanine scanning
mutations in the core of -actin site Ii. Signals indicate the
interaction between CCT and soluble N-terminally biotinylated peptides
corresponding to -actin site Ii (peptide sequence 8 and mutants
thereof; Table I). CCT (70 nM) was incubated with peptide
(13.3 µM, lanes 1 and 3-7; 1.33 µM, lane 2), and interactions were detected on
6% native PAGE gels. Lanes 3-7 show the interaction of
peptides containing five alanine scanning point mutations across the
core sequence of -actin site Ii (36GRPRH40).
The mutant peptides showed equivalent (lane 6,
36GRPAH40; lane 7,
36GRPRA40), reduced (lane 4,
36GAPRH40), or enhanced (lane 3,
36ARPRH40; lane 5,
36GRARH40) binding to CCT. Replacement of all
five residues of the GRPRH core sequence by five alanines resulted in
complete abrogation of binding (lane 8,
36AAAAA40).
|
|
Mutation of
-Actin Site Ii--
We have focused our attention
on
-actin site Ii, a high affinity site that occupies three
overlapping peptides and spans amino acid residues 26-50 of
-actin
subdomain 2 (Table I and Fig. 6A). We demonstrated the
interaction between CCT and N-terminally biotinylated peptide in
solution. CCT and peptide corresponding to
-actin site Ii (Table I;
peptide 8) were incubated together, and the reactions were then
electrophoresed on native PAGE gels, electrotransferred to
nitrocellulose membrane, and probed with streptavidin-horseradish
peroxidase conjugate to detect the biotinylated peptide (Fig.
6B, lanes 1 and 2). A biotin signal
co-migrating with CCT was detectable within a 10-fold concentration
range of peptide (1.33-13.3 µM) and fixed concentration
of CCT (70 nM). Five alanine scan point mutations across
the core sequence (36GRPRH40) of
-actin site
Ii were screened for effects on interaction with CCT (Fig.
6B, lanes 3-7). The mutant peptides showed
equivalent, reduced, or enhanced binding but not absence of binding,
although replacement of all five residues of the GRPRH core sequence by AAAAA resulted in abrogation of binding to CCT. Although essentially an
analytical approach, it indicates that there is a bona fide interaction between the site Ii peptide and CCT and that it is avid
enough to survive electrophoresis and Western blotting.
Remarkably, even within the context of a short peptide, individual
residues in the core binding motif (36GRPRH40)
are contributing to the overall ensemble of CCT-binding conformation(s) of the peptide. The significance of the increased binding by two peptides, 36ARPRH40 and
36GRARH40, is unclear but may indicate
involvement of induced fit in the binding reaction. Furthermore, it is
understandable that maximal binding affinity of CCT-binding motifs of
actin may not be a desirable feature of the system, because CCT has
ultimately to release actin upon completion of folding.
 |
DISCUSSION |
Chaperonin Interactions with Polypeptide Substrates--
It is a
tenet in the field of chaperonin research that interactions between
chaperonin and substrates are mediated predominantly through
hydrophobic interactions (1, 35). This view has its strongest direct
support via mutagenesis of hydrophobic residues in the apical
polypeptide chain binding domains of the type I chaperonin of
Escherichia coli, GroEL; when several hydrophobic residues
are changed to charged residues, substrate binding is abrogated (36).
An x-ray structure of the GroEL apical domain in isolation reveals a
direct interaction between an artificial N-terminal peptide tag and
residues located in
-helices 8 and 9 of the apical domain (37).
Most recently, a crystal structure of the complex formed between a
model peptide and GroEL tetradecamer has been solved (38). The
interaction of the model peptide with GroEL is proposed to mimic the
binding of a substrate. The peptide is bound in a hydrophobic groove
between
-helices 8 and 9 in the apical domain, notably the same site
occupied by the N-terminal peptide tag (37) and GroES mobile loop in
the structure of the GroEL-GroES complex (39). Thus, the GroEL
substrate binding site appears to be capable of accommodating many
different amino acid sequences. The interactions between the bound
peptide ligands and apical domain surface are a mixture of hydrophobic
and polar contacts. In each case, hydrophobic side chains from the
peptide are buried in hydrophobic pockets in the binding site, and a
number of hydrogen bonds are formed between polar side chains in the
apical domain and the peptide backbone. Recently, Hartl and colleagues
(40) have examined the spectrum of substrate proteins that interact
with GroEL in vivo and have found several hundred GroEL
interacting proteins, some of which seem to share the common feature of
domains with 
-folds. It may be the hydrophobic residues in the
buried
-sheets of these types of secondary structural elements that
are preferentially bound by GroEL.
The type II chaperonins of archaebacteria and eukaryotic cytosol are
much less well characterized than GroEL in most respects. X-ray
structural analyses of the thermosome indicate significant differences
compared with GroEL in the structure of its apical domains (41, 42).
Particularly surprising is the absence of hydrophobic residues in the
region of the thermosome apical domain corresponding to the substrate
binding site of GroEL, suggesting to us that the physico-chemical
nature of interaction between substrate and chaperonin could be
significantly different in the thermosome (10); however, others have
proposed that the substrate interaction sites are located elsewhere on
the apical domains, such as in the helical protrusions (41).
Presently, there is very little known about the natural substrates of
archaebacterial type II chaperonins (43) but, in the case of CCT, there
is a large body of data that indicates actins and tubulins as major
in vivo substrates (10). It is the nature of the
interactions between CCT and its natural substrates that we are
interested in elucidating.
It has been suggested in previous studies that both actins (31, 44) and
tubulins (30) interact with CCT through defined hydrophobic regions and
that CCT functions exactly like GroEL (45). However, the type I
chaperonin GroEL can bind chemically denatured actin, presumably
through hydrophobic interactions, and yet actin cannot be productively
folded by GroEL (46). This is puzzling because it indicates that GroEL
is unable to provide some aspect of specificity to the folding of actin
that is imparted by CCT.
Recently, the first structure of any chaperonin bound with substrate
was obtained when Llorca and colleagues (12) determined a structure of
-actin bound to nucleotide-free CCT by cryo-electron microscopy.
This complex probably resembles an early conformation in the presumably
complicated series of interactions that occur sequentially between CCT
and actin during the complete, but presently ill defined, folding cycle
(12). Although the apo-CCT-
-actin structure represents a
"snapshot" of the interaction between CCT and actin, it seems that,
at least at one stage, the interaction is both geometry-specific and
subunit-specific. This structure is immediately suggestive of a model
in which the interaction between actin and CCT is sequence-specific
with respect to both the chaperonin and substrate components. One can
imagine that
-actin is opened up across the nucleotide binding cleft
when bound to apo-CCT and that CCT is holding
-actin via the tips of
the arms of the small and large domains (12). The biochemical studies
reported in this paper strongly support the structural model because we
find that 15-mer peptide sequences derived from the tips of the small
and large domains of actin react strongly with CCT. In addition, the
apo-CCT-
-actin structure shows that CCT
interacts with subdomain
2 and that either CCT
or CCT
can interact with subdomain 4, and
once more, in this study immunoprecipitation of mixed micelle detergent
disrupted CCT-
-actin complexes with all eight anti-CCT subunit
antibodies directly supports this model. We should emphasize that the
CCT-
-actin complexes that we have analyzed biochemically were formed
under the physiological conditions of in vitro translation
in rabbit reticulocyte lysate. Because the CCT-
-actin complexes are
derived under physiological conditions, we presume that there exists a
mixture of CCT-actin complexes recovered in different stages of the
reaction cycle, and this may account for the additional interactions
observed between actin and CCT subunits, such as CCT
and CCT
.
Model of Interaction between CCT and Actin--
A previous
approach to investigate which regions of actin are bound by CCT
involved the study of interaction of truncated actin molecules to CCT
upon in vitro translation in rabbit reticulocyte lysate
(31). In the context of the new structure and our biochemical data,
reinterpretation of some of the data of Rommelaere et al. (31) is now possible. In their study, they constructed a large series
of N- and C-terminal truncation mutants and found evidence for several
specific regions of actin involved in CCT interaction, some of which
overlap regions that we now implicate in binding. However, their study
did not take into account the native structure of
-actin, nor were
they able to distinguish between deletions that enhanced or reduced
binding from those that might have affected processing and release. We
have shown that a fusion protein of the Ha-Ras small GTP-binding
protein linked to subdomain 4 of
-actin can bind to the CCT
and
CCT
subunits by structural analysis (12) and here directly by
immunoprecipitation. This fusion protein migrates as a discrete species
in native PAGE and exists in equilibrium between an unbound and a
CCT-bound in time course analysis upon in vitro translation
in rabbit reticulocyte lysate (12). We surmise that in this fusion
protein the
-actin subdomain 4 component is in a conformation that
resembles the conformation of this domain in the
-actin folding
intermediate, which is the normal substrate for CCT, and thus enables
its capture by CCT. Furthermore, the existence of a stable CCT-binding
subdomain of actin can be understood in the context of our model
because we suggest that actin binds to CCT through regions that
are finally found exposed in the native actin structure rather than
transiently exposed hydrophobic residues normally found buried in the
core of the native protein.
There are aspects of the association of
-actin with CCT that we do
not yet understand. In particular, why some interactions between actin
subdomains and individual CCT subunits in the holo-chaperonin are
resistant to mixed micelle detergent conditions (e.g.
interactions mediated by CCT
, CCT
, CCT
, and CCT
), whereas
others appear susceptible (e.g. interactions mediated by
CCT
). Furthermore, why two types of interaction occur between
-actin and CCT
, and CCT
, dependent upon whether these subunits
are components of the holo-chaperonin or populations of dissociated
monomers. Thus, it is likely that a series of reactions are occurring
during actin folding on CCT. We have no structural information on the
nature of ATP-CCT-
-actin complexes, but we already know that the
structure of ATP-CCT (6) has a hemispherical folding cavity in a very different conformation to the
-actin bound ring in the
apo-CCT-
-actin structure (12). Biochemical studies demonstrate that
CCT can be induced to release its bound actin in the presence of Mg-ATP (this study) (22). No doubt further three-dimensional structures and
biochemical studies of the interaction of actin with CCT will help in
understanding its maturation pathway on CCT, which takes several
minutes to complete in vivo in mammalian cells at 37 °C (47).
In conclusion, we believe that the mode of interaction between CCT and
actin is likely to be between residues exposed on the surface of a
compact quasi-native folding intermediate and specific CCT subunits.
The new structure of apo-CCT-
-actin is also consistent with this
model because the actin binds well below the helical protrusions of the
apical domains to regions enriched in charged rather than hydrophobic
residues (41). It may be time to give serious consideration to the
possibility that the substrate recognition mechanisms of GroEL and CCT
are very different from one another.
 |
ACKNOWLEDGEMENTS |
We thank Damian Counsell for bioinformatic
analysis, Angela Paul for amino acid analysis, Elizabeth McCormack for
the
-actin.sub4 cDNA plasmid, Martin Smyth for purified
Hsc/Hsp70, José Valpuesta for comments on the manuscript, and
Sylvia Holt for manuscript preparation.
 |
FOOTNOTES |
*
This work was supported by the Cancer Research Campaign.The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
To whom correspondence should be addressed: Inst. of Cancer
Research, Chester Beatty Laboratories, 237 Fulham Rd., London SW3 6JB,
UK. Tel.: 44-020-7878-3834; Fax: 44-020-7351-3325.
Published, JBC Papers in Press, March 21, 2000, DOI 10.1074/jbc.M910297199
 |
ABBREVIATIONS |
The abbreviations used are:
CCT, chaperonin
containing TCP-1;
PAGE, polyacrylamide gel electrophoresis;
PBS.A, Dulbeccos's phosphate-buffered saline solution A;
mAb, monoclonal
antibody.
 |
REFERENCES |
| 1.
|
Bukau, B.,
and Horwich, A. L.
(1998)
Cell
92,
351-366
|
| 2.
|
Willison, K. R.,
and Horwich, A. L.
(1996)
in
The Chaperonins
(Ellis, R. J., ed)
, pp. 107-135, Academic Press Inc., Orlando, FL
|
| 3.
|
Archibald, J. M.,
Logsdon, J. M.,
and Doolittle, W. F.
(1999)
Curr. Biol.
9,
1053-1056
|
| 4.
|
Marco, S.,
Carrascosa, J. L.,
and Valpuesta, J. M.
(1994)
Biophys. J.
67,
364-368
|
| 5.
|
Liou, A. K. F.,
and Willison, K. R.
(1997)
EMBO J.
16,
4311-4316
|
| 6.
|
Llorca, O.,
Smyth, M. G.,
Carrascosa, J. L.,
Willison, K. R.,
Radermacher, M.,
Steinbacher, S.,
and Valpuesta, J. M.
(1999)
Nat. Struct. Biol.
6,
639-642
|
| 7.
|
Grantham, J.,
Llorca, O.,
Valpuesta, J. M.,
and Willison, K. R.
(2000)
J. Biol. Chem.
275,
4587-4591
|
| 8.
|
Kubota, H.,
Hynes, G.,
Carne, A.,
Ashworth, A.,
and Willison, K.
(1994)
Curr. Biol.
4,
89-99
|
| 9.
|
Willison, K. R.,
and Kubota, H.
(1994)
The Biology of Heat Shock Proteins and Molecular Chaperones
, pp. 299-312, Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY
|
| 10.
|
Willison, K. R.
(1999)
in
Molecular Chaperones and Folding Catalysts. Regulation, Cellular Function and Mechanisms
(Bukau, B., ed)
, pp. 555-571, Harwood Academic Publishers
|
| 11.
|
Kim, S.,
Willison, K. R.,
and Horwich, A. L.
(1994)
Trends Biochem. Sci.
19,
543-548
|
| 12.
|
Llorca, O.,
McCormack, E. A.,
Hynes, G.,
Grantham, J.,
Cordell, J.,
Carrascosa, J. L.,
Willison, K. R.,
Fernandez, J. J.,
and Valpuesta, J. M.
(1999)
Nature
402,
693-696
|
| 13.
|
Liou, K. F.,
McCormack, E. A.,
and Willison, K. R.
(1998)
Biological Chem. Hoppe-Seyler
379,
311-319
|
| 14.
|
Hynes, G.,
Kubota, H.,
and Willison, K. R.
(1995)
FEBS Lett.
358,
129-132
|
|